Pages that link to "Q37334618"

The following pages link to Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon (Q37334618):

Displaying 43 items.

• AID and APOBECs span the gap between innate and adaptive immunity (Q21131084) (← links)
• The role of BST-2/Tetherin in host protection and disease manifestation (Q26752737) (← links)
• Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties (Q28385082) (← links)
• Interleukin-27 is differentially associated with HIV viral load and CD4 T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese (Q33590441) (← links)
• Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection (Q33712080) (← links)
• Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4( ) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients (Q33713794) (← links)
• Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication (Q33728042) (← links)
• CD56 T cells inhibit HIV-1 infection of macrophages (Q33730835) (← links)
• IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination. (Q33795818) (← links)
• The macrophage in HIV-1 infection: from activation to deactivation? (Q33810779) (← links)
• The mouth: a gateway or a trap for HIV? (Q33874252) (← links)
• A novel role for Slit2/Robo1 axis in modulating HIV-1 replication in T cells (Q34009882) (← links)
• Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus (Q34242185) (← links)
• IL-27-induced gene expression is downregulated in HIV-infected subjects. (Q34438335) (← links)
• Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a) (Q34461242) (← links)
• Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway (Q34634806) (← links)
• Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation (Q35041156) (← links)
• In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans (Q35170879) (← links)
• Structural variants of IFNα preferentially promote antiviral functions (Q35197399) (← links)
• Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severity (Q35242525) (← links)
• Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo (Q35634220) (← links)
• Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo (Q35684549) (← links)
• Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling (Q35874404) (← links)
• Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. (Q36370053) (← links)
• IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. (Q36463634) (← links)
• Maintenance of CMV-specific CD8 T cell responses and the relationship of IL-27 to IFN-γ levels with aging (Q36585832) (← links)
• Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy (Q36633351) (← links)
• IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation (Q36694200) (← links)
• Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion (Q36929123) (← links)
• Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection (Q37365279) (← links)
• Innate immune receptors in skeletal muscle metabolism. (Q39148436) (← links)
• Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner (Q39727068) (← links)
• BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity (Q40279352) (← links)
• Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway (Q40621223) (← links)
• Understanding the regulation of APOBEC3 expression: Current evidence and much to learn. (Q47552005) (← links)
• Interferons and beyond: Induction of antiretroviral restriction factors (Q47552023) (← links)
• IL-27 Expression and Responsiveness in Human Uterine Epithelial Cells and Fibroblasts In Vitro and the Role of Estradiol. (Q52642797) (← links)
• Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. (Q52723506) (← links)
• Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression (Q64279721) (← links)
• Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses. (Q64971881) (← links)
• Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection (Q90690250) (← links)
• Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27 (Q92199134) (← links)
• Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases (Q99605551) (← links)